awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33442755-DBE23691-CF5C-4F4A-942C-1E8B97C9C323
Q33442755-DBE23691-CF5C-4F4A-942C-1E8B97C9C323
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33442755-DBE23691-CF5C-4F4A-942C-1E8B97C9C323
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma.
P2860
Q33442755-DBE23691-CF5C-4F4A-942C-1E8B97C9C323
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33442755-DBE23691-CF5C-4F4A-942C-1E8B97C9C323
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a2b14d32d169786dbd7491eb76dc7ed856bacfe
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.